Re: ONXX Nexavar approved (PFE) Let the competition begin! PFE’s Sutent has a decent chance to be approved in February. -- PFE bombed with Macugen and Oporia (so far), but the market may be underestimating the potential oomph from Sutent, Exubera, and Indiplon.